US Patent Issued to United Biomedical on Oct. 14 for "Peptide immunogens and formulations thereof targeting membrane-bound IgE for treatment of IgE mediated allergic diseases" (American, Taiwanese Inventors)

ALEXANDRIA, Va., Oct. 21 -- United States Patent no. 12,440,557, issued on Oct. 14, was assigned to United Biomedical Inc. (Hauppauge, N.Y.).

"Peptide immunogens and formulations thereof targeting membrane-bound IgE for treatment of IgE mediated allergic diseases" was invented by Chang Yi Wang (Cold Spring Harbor, N.Y.), Feng Lin (Hauppauge, N.Y.) and Jiun Bo Chen (Hauppauge, Taiwan).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure is directed to peptide immunogen constructs targeting the extracellular membrane-proximal domain of membrane-bound IgE (or IgE EMPD) and formulations thereof for the treatment of IgE-mediated allergic diseases. The IgE EMPD peptide immunogen constructs have a B...